Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. - Wikidata - awgldk - TriplyDB

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.

http://www.wikidata.org/entity/Q44189756

about

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.Altered immunophenotypic features of peripheral blood platelets in myelodysplastic syndromes.Decreased CD10 Expression in the Bone Marrow Neutrophils of HIV Positive Patients Establishment and validation of an updated diagnostic FCM scoring system based on pooled immunophenotyping in CD34+ blasts and its clinical significance for myelodysplastic syndromes.Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes.Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes.Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study Myelodysplastic syndrome with myelofibrosis transformed to a precursor B-cell acute lymphoblastic leukemia: a case report with review of the literature.Clinical implications of blast immunophenotypes in myelodysplastic syndromes.Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts.Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques.Myelodysplastic syndromes: clinical practice guidelines in oncology.Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.Diagnostic challenges in the myelodysplastic syndromes: the current and future role of genetic and immunophenotypic studies.Role of flow cytometry in myelodysplastic syndromes: diagnosis, classification, prognosis and response assessment.Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias.Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.Assessment of erythroid dysplasia by "difference from normal" in routine clinical flow cytometry workup.Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.Biological studies on the effect of estrogen on experimentally induced asthma in mice.Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome.Assessment of normal erythropoiesis by flow cytometry: important considerations for specimen preparation.Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review.Immunophenotypic analysis of erythroid dysplasia and its diagnostic application in myelodysplastic syndromes.Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes.Value of Quantitative assessment of Myeloid Nuclear Differentiation Antigen expression and other flow cytometric parameters in the diagnosis of Myelodysplastic syndrome.Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes.

P2860

Q33393647-C9CB67B9-713F-4119-81A2-59FD2B6BEF8B Q33399314-1A4C9710-1DBB-4BD7-A28F-6C4BE7D60B0F Q35098988-D95C609F-150A-4039-91AF-6DA6CD561195 Q35099645-FB39B655-06AC-4D95-AF64-E31D1C61ED5D Q35809442-93FB655A-15B4-4316-AB77-9CF3C38D9351 Q36031954-2BD1D41E-A275-47D0-8A66-B7F5166BD00B Q36133023-9C0058BB-3639-4A2E-9BDF-DF69DC44CEB9 Q36169249-136DACF8-AD23-4EB2-9A2A-93D5D7EC31D2 Q36234493-E760BE9C-127D-4128-9175-EDF631BF08D5 Q36784986-ADC872E5-5BD2-4A34-B6B5-16CD40F8C9E2 Q36963592-5BC006B1-F87C-4C10-9E0E-CD61F5CF6E44 Q37284393-1A1D15F4-7B69-42C1-AA55-30192BECA639 Q37366069-D8547E78-02DC-4A5C-9D72-729DA8051301 Q37723847-7D5C531F-3DF8-4965-B338-6B1C0EAD8526 Q37889846-45996ED9-D5BB-423A-8718-6D6CC92971F8 Q38089064-82E6BBCD-17D2-4672-B0D8-E93C22C30D43 Q38117677-EBE1F10F-17D0-43C8-9705-03426B97E8EF Q38908087-DC6BA585-DFDF-48B3-9331-CA03B62C772E Q39757098-25060FB2-BF93-4C63-A87D-73625DD29DA7 Q39968886-AF2F378A-2A96-48E5-9C2F-F1DAB28E9B2A Q41711144-800260C6-2533-453F-BFB8-D7A0504C5218 Q42662183-4C681DFD-0112-4892-8EBF-767899475E6E Q43650499-A64AC0C7-2ED4-473B-AC20-26B6EA98B877 Q45069419-9BC89238-E460-48D8-9B4D-03DF25146DC6 Q46402910-AFF7F6E3-382C-424B-9A17-75FB3884505D Q46960830-943B0B9F-D4B9-4DB0-A76F-55049A7B2A1D Q46967957-7252705D-32E1-4D43-A1CB-29638CA28F34 Q47124670-FB2ADEBD-8ABB-4B78-B40D-BC10B6BE9937 Q47145316-DB3339A4-62AE-4651-B23B-0DF9642911A2 Q50523970-F560824C-BC69-453D-B04B-1DD80D0DD084 Q51763561-E7266B09-CDFF-47E0-9451-7F39AB454520 Q52886979-6396F79A-C97A-47DF-AB66-2B00C9D447EB Q53237344-39909AD7-8228-4A9A-B357-27F8B5F46A73 Q55360759-3821BF8B-BBF1-445A-B210-C1223FF8CEB6

P2860

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.

http://www.wikidata.org/entity/Q44189756

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Clinical significance of pheno ...... with myelodysplastic syndrome.

@en

Clinical significance of pheno ...... with myelodysplastic syndrome.

@nl

type

label

Clinical significance of pheno ...... with myelodysplastic syndrome.

@en

Clinical significance of pheno ...... with myelodysplastic syndrome.

@nl

prefLabel

Clinical significance of pheno ...... with myelodysplastic syndrome.

@en

Clinical significance of pheno ...... with myelodysplastic syndrome.

@nl

P1433

Q44189756-156211C3-846B-43AD-83DD-A136DB2F4EE5

P1476

Q44189756-054CA595-010A-4B5F-824B-A076328ACFF6

P2093

Q44189756-022A16A4-980D-4CD0-BA40-3635992E8F22

Q44189756-095111C9-CCA1-41AE-97FD-2587E0E12E64

Q44189756-0CD573A9-7E04-4E0F-85DD-9547E0E0DD72

Q44189756-0FB3670F-66FA-4C61-AF94-A86100265960

Q44189756-297E8AF3-05ED-4C8C-B95F-00BD375C0DDB

Q44189756-42E79628-865D-4432-A66B-E085A3EE73BA

Q44189756-4C17A97C-F59D-4B46-983A-1ABFACDFE849

Q44189756-64A9003C-8513-4EA0-B0D4-BCD8F095F1A1

Q44189756-6D5E9EE1-8713-49A4-A49C-B45EF79607CF

Q44189756-7488B0D6-2C2B-44D3-8F61-D839997E9B96

P304

Q44189756-ADAD5711-A2D7-4A79-B4F5-778D457D87EE

P31

Q44189756-9F9C03FA-F166-4F99-BB38-A70D43782592

P356

Q44189756-C93B7B01-1827-41C0-B1C1-051605CF07B0

P407

Q44189756-BFB98FC1-CF15-4004-87C1-AC07246E5B8C

P433

Q44189756-823B23DB-5DB7-44BA-9325-DE88252AF2E7

P478

Q44189756-90E81D8F-37C9-4310-A3EE-85BE101ADEBC

P577

Q44189756-042C9E2C-A0B4-417D-9F41-8C8E9431A14F

P5875

Q44189756-7900E8BA-7165-4890-A0B0-129C43D1AE93

P698

Q44189756-DB2D1C1D-6B11-4DF7-B6D9-44CF2B1D49B0

P356

BLOOD-2002-01-0222

P1433

P1476

Clinical significance of pheno ...... with myelodysplastic syndrome.

@en

P2093

Hideto Tamura

http://www.w3.org/2001/XMLSchema#string

Hisashi Sakamaki

http://www.w3.org/2001/XMLSchema#string

Kaoru Tohyama

http://www.w3.org/2001/XMLSchema#string

Kazuo Dan

http://www.w3.org/2001/XMLSchema#string

Kiyoyuki Ogata

http://www.w3.org/2001/XMLSchema#string

Kyoko Nakamura

http://www.w3.org/2001/XMLSchema#string

Mayumi Mori

http://www.w3.org/2001/XMLSchema#string

Mikiko Tachibana

http://www.w3.org/2001/XMLSchema#string

Norio Yokose

http://www.w3.org/2001/XMLSchema#string

Osamu Taniguchi

http://www.w3.org/2001/XMLSchema#string

P304

3887-3896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2002-01-0222

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P577

2002-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11068604

http://www.w3.org/2001/XMLSchema#string

P698

12393641

http://www.w3.org/2001/XMLSchema#string